Krystal Biotech, Inc. (KRYS)
291.93
+19.80
(+7.28%)
USD |
NASDAQ |
Jan 13, 16:00
291.90
-0.04
(-0.01%)
After-Hours: 20:00
Krystal Biotech Research and Development Expense (Annual): 53.57M for Dec. 31, 2024
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| DexCom, Inc. | 545.70M |
| BioLife Solutions, Inc. | 7.912M |
| Alnylam Pharmaceuticals, Inc. | 1.126B |
| Catalyst Pharmaceuticals, Inc. | 12.65M |
| Amicus Therapeutics, Inc. | 109.36M |